A prospective study of the beneficial effects of dose optimization and customized instructions on patient satisfaction with sildenafil citrate (Viagra®) for erectile dysfunction

Urology

Volumn 68, Issue 3 SUPPL., 2006, Pages 38-46

  Mccullough, Andrew R ^a   Carson, Culley C ^b   Hatzichristou, Dimitrios ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIZZINESS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PATIENT SATISFACTION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHOTOPHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; STROKE; SYNCOPE; TACHYCARDIA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL PROTOCOLS; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PROSPECTIVE STUDIES;

EID: 33748956845     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.04.040     Document Type: Article

References (24)

1. Hatzimouratidis K., and Hatzichristou D.G. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?. Drugs 65 (2005) 1621-1650
2. Goldstein I., Lue T.F., Padma-Nathan H., et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 338 (1998) 1397-1404
3. Dinsmore W.W., Hodges M., Hargreaves C., et al. Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects. Urology 53 (1999) 800-805
4. Eardley I., Morgan R., Dinsmore W., et al. Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction. Br J Psychiatry 178 (2001) 325-330
5. Jiann B.P., Yu C.C., Tsai J.Y., et al. What to learn about sildenafil in the treatment of erectile dysfunction from 3-year clinical experience. Int J Impot Res 15 (2003) 412-417
6. McCullough A.R., Barada J.H., Fawzy A., et al. Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction. Urology 60 (2002) 28-38
7. Atiemo H., Szostak M., and Sklar G. Salvage of sildenafil failures referred from primary care physicians. J Urol 170 pt 1 (2003) 2356-2358
8. Jiann B.P., Yu C.C., Su C.C., et al. Rechallenge prior sildenafil nonresponders. Int J Impot Res 16 (2004) 64-68
9. Hatzichristou D., Moysidis K., Apostolidis A., et al. Sildenafil failures may be due to inadequate patient instructions and follow-up: a study on 100 non-responders. discussion 522-513. Eur Urol 47 (2005) 518-522
10. McMurray J., Feldman R., Auerbach S., et al. Long-term effectiveness and tolerability of Viagra (sildenafil citrate) in men with erectile dysfunction. [abstract]. Int J Impot Res 14 suppl 3 (2002) S104
11. Steers W., Guay A.T., Leriche A., et al. Assessment of the efficacy and safety of Viagra (sildenafil citrate) in men with erectile dysfunction during long-term treatment. Int J Impot Res 13 (2001) 261-267
12. Morales A., Gajewski J.B., Pommerville P.J., et al. 3-year efficacy and safety of Viagra in men with erectile dysfunction: results of Canadian long-term extension study. [abstract]. Can J Urol 10 (2003) 1826
13. Althof S.E., Corty E.W., Levine S.B., et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 53 (1999) 793-799
14. Rosen R.C., Riley A., Wagner G., et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822-830
15. Cappelleri J.C., Rosen R.C., Smith M.D., et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 54 (1999) 346-351
16. Wysowski D.K., and Swann J. Use of medications for erectile dysfunction in the United States, 1996 through 2001. J Urol 169 (2003) 1040-1042
17. Data on file (2005), Pfizer Inc, New York, NY
18. Marks L.S., Duda C., Dorey F.J., et al. Treatment of erectile dysfunction with sildenafil. Urology 53 (1999) 19-24
19. Jarow J.P., Burnett A.L., and Geringer A.M. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment. J Urol 162 (1999) 722-725
20. Virag R. Indications and early results of sildenafil (Viagra) in erectile dysfunction. Urology 54 (1999) 1073-1077
21. McMahon C.G., Samali R., and Johnson H. Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction. J Urol 164 (2000) 1192-1196
22. Harrold L.R., Gurwitz J.H., Field T.S., et al. The diffusion of a novel therapy into clinical practice: the case of sildenafil. Arch Intern Med 160 (2000) 3401-3405
23. Levinson I.P., Stecher V.J., Siegel R.L., et al. Optimal dosing of sildenafil citrate for the treatment of erectile dysfunction: pooled analyses of flexible- and fixed-dose, placebo-controlled, double-blind and open-label extension studies (2005) Presented at the American Urological Association Annual Meeting; May 21-26, San Antonio, Texas.
24. ® (sildenafil citrate) for the treatment of erectile dysfunction: pooled analysis of flexible-dose, placebo-controlled, double-blind studies and open-label extension. [abstract]. J Sex Med 2 suppl 1 (2005) 36